Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion type Assertion NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_head.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion description "[In contrast to NPM-ALK-negative ALCL, the mTOR pathway is active in NPM-ALK-positive lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_provenance.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion evidence source_evidence_literature NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_provenance.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion SIO_000772 17690253 NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_provenance.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion wasDerivedFrom befree-2016 NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_provenance.
- NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_assertion wasGeneratedBy ECO_0000203 NP624394.RAtMiKw87jiAXFKjU7QEUG9hPgUjivvgZpsX2fuaBS6Uc130_provenance.